For example, in our real data application based on the Alzheimer’s disease neuroimaging initiative (ADNI) database, we aim to explore the association between cerebrospinal fluid tau protein levels (CSF-tau) and the severity of Alzheimer’s disease (AD). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.